Whether you're leaving Found for cost, simplicity, or a different program structure, the same three things determine a smooth next step: sequencing your transfer, sharing your treatment history, and choosing a provider whose pricing and support model actually fits you.
Luma Health's flat semaglutide ($197/month) and tirzepatide ($297/month) include a medical evaluation to plan the transition.
Patients leaving Found are usually looking for one of a few specific things: lower cost, simpler pricing, or a program without the multi-tier structure. Here's how to find the right next step and make the switch cleanly.
Step 1: Clarify What You're Actually Optimizing For
Before choosing a new provider, get specific about your main priority: lowest total cost, simplest pricing structure, keeping behavioral coaching, or something else. Different providers solve for different priorities, so knowing yours narrows the decision considerably.
Step 2: Know What to Look for in a New Provider
Regardless of your specific priority, look for: transparent, all-inclusive pricing (or at minimum, clear disclosure of every separate fee), a real medical evaluation rather than a rubber-stamp approval, licensed pharmacy sourcing you can independently verify, and ongoing provider access included in the price.
Luma Health's compounded semaglutide is $197/month and tirzepatide is $297/month, flat, prepared by VialsRx, a 503A pharmacy licensed by the Texas State Board of Pharmacy (license #35264, verifiable at pharmacy.texas.gov). No separate membership fee, no plan tiers to navigate.
Step 3: Sequence Your Switch to Avoid a Gap
Start your new provider's medical evaluation while you still have 2-3 weeks of medication remaining from Found. Share your current dose, treatment duration, and any side effects during intake. Once your new prescription is approved and shipping, cancel Found, confirming your exact billing cycle first.
Step 4: Carry Forward Any Recent Lab Work
If Found ordered labs for you recently, ask whether you can get a copy to share with your new provider — this can sometimes reduce or eliminate a repeat lab requirement depending on how recent the results are.
Choosing Your Next Step
- Whether cost, simplicity, or coaching features matter most to you
- Your current dose and treatment history to share
- Your Found billing cycle, to time cancellation correctly
- Transparent pricing matching what you're actually optimizing for
- A real medical evaluation, not a rubber stamp
- Verifiable pharmacy licensing
A clear next step,
one flat price
Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included.
Get Started → Or start your free health assessmentFrequently Asked Questions
Cost and pricing complexity are common reasons, given Found's multi-tier structure with separately billed membership, medication, and sometimes labs.
Start your new provider's medical evaluation while you still have 2-3 weeks of medication remaining, so your new prescription ships before your current supply runs out.
Not if you share your current dose and treatment history with your new provider, allowing them to continue at an appropriate level rather than restarting titration unnecessarily.
Possibly — ask for a copy and share it with your new provider, which may reduce or eliminate the need for repeat labs depending on recency.
Transparent pricing, a real medical evaluation, verifiable pharmacy licensing, and ongoing provider access included in the price — regardless of your specific reason for switching.
After your new prescription is approved and shipping, timed just before your next Found billing cycle to avoid an extra charge.
References
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PubMed 35441470
- Texas State Board of Pharmacy. Pharmacy license lookup and verification. pharmacy.texas.gov
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov